Company: IPSC
Filing Date: 2025-12-02
Form Type: DEF 14A
Source: 0001104659-25-117704
Chunk: 13

Company: Century Therapeutics, Inc.
Filing Date: 2025-12-02
Form: DEF 14A
Chunk 13
---
, would be determined by our Board in its sole discretion and publicly announced by us prior to the effective time of the Notice of Special Meeting of Stockholders and 2025 Proxy Statement | 6

| ​ | ITEMS TO BE VOTED ON | ​ |

Reverse Stock Split. In determining whether to proceed with the Reverse Stock Split and setting the appropriate ratio for the Reverse Stock Split, if any, our Board may consider, among other things, factors such as: • our ability to maintain the listing of our Common Stock on the Nasdaq Capital Market; • the per share price of our Common Stock immediately prior to the Reverse Stock Split; • the historical market prices and trading volume of our Common Stock and the anticipated or actual impact of the Reverse Stock Split on the market prices and trading volume for our Common Stock; • the number of shares of our Common Stock outstanding prior to and after the Reverse Stock Split; • the likelihood that the Reverse Stock Split will result in increased marketability and liquidity of our Common Stock; and • prevailing general market and economic conditions. Certain Risks Associated with the Reverse Stock Split Even if the Reverse Stock Split is effected, we may not be able to satisfy all of the other requirements for continued listing of our Common Stock on the Nasdaq Capital Market or other stock exchange. As discussed above, the Board is submitting the proposed Reverse Stock Split to our stockholders for approval with the primary intent of increasing the minimum bid price of our Common Stock to regain and maintain compliance with the listing requirements of the Nasdaq Capital Market and to make our Common Stock more attractive to a broader range of institutional and other investors. However, continued listing on such exchange requires compliance with a variety of other qualitative and quantitative listing standards. Even if we effect the Reverse Stock Split, we may not be able to satisfy or maintain listing requirements on the Nasdaq Capital Market or any other stock exchange. We cannot provide any assurances that we will be able to maintain a listing of our Common Stock on the Nasdaq Capital Market or any other stock exchange. The Reverse Stock Split May Not Increase the Price of our Common Stock over the Long-Term As noted above, the principal purpose of the Reverse Stock Split is to increase the trading price of our Common Stock to meet the minimum stock price standards of Nasdaq. However, the effect of the Reverse Stock Split on the market price of our Common Stock cannot be predicted with any certainty, and we cannot assure you that the Reverse Stock Split will accomplish this objective for any meaningful period of time, or at all. While we expect